Ultrapar Holdings Inc 6-K, filed May 19, 2021
Ultrapar Holdings Inc (UGP)
About this 6-K
Ultrapar Holdings Inc filed this 6-K on May 19, 2021.
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
|
Form 6-K |
Report of Foreign Private Issuer
Pursuant to Rule 13a-16 Or 15d-16 Of
The Securities Exchange Act Of 1934
For the month of May, 2021
Commission File Number: 001-14950
ULTRAPAR HOLDINGS INC.
(Translation of Registrant’s Name into English)
Avenue Brigadeiro Luis Antonio, 1343, 9th Floor
São Paulo, SP, Brazil 01317-910
(Address of Principal Executive Offices)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:
Form 20-F ____X____ Form 40-F ________
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):
Yes ________ No ____X____
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):
Yes ________ No ____X____
ULTRAPAR HOLDINGS INC.
TABLE OF CONTENTS
ITEM
| 1. | Minutes of the Meeting of the Board of Directors of Ultrapar Participações S.A., held on May 18, 2021. |
ULTRAPAR PARTICIPAÇÕES S.A.
Publicly Traded Company
|
CNPJ nº 33.256.439/0001-39 |
NIRE 35.300.109.724 |
MINUTES OF THE MEETING OF THE BOARD OF DIRECTORS
Date, Hour and Place:
May 18, 2021, at 8:30 am, held under the terms of art. 24, paragraph 4 of the Company's Bylaws.
Members in Attendance:
(i) Members of the Board of Directors undersigned; (ii) Secretary of the Board of Directors, Mr. André Brickmann Areno; (iii) Chief Executive Officer, Mr. Frederico Pinheiro Fleury Curado; and (iv) Chief Financial and Investor Relations Officer, Mr. Rodrigo de Almeida Pizzinatto.
Matters discussed and resolutions:
1. Pursuant to the terms of art. 28, subheading “p”, item v, of the Company's Bylaws, the members of the Board of Directors approved the sale by their wholly-owned subsidiary Ipiranga Produtos de Petróleo S.A. of all the shares issued by Imifarma Produtos Cosméticos e Farmacêuticos S.A., pursuant to the proposal filed at the Company's headquarters.
2. In view of the resolution cited above, the members of the Board of Directors determined to call an extraordinary general shareholders’ meeting of the Company for the purpose of exercising the preemptive rights, in compliance with article 253 of the Brazilian Corporate Law.
3. The Company's Executive Officers are authorized to perform all acts and to execute all documents related to the conclusion of the negotiations, as well as the conclusion and accomplishment of this sale.
Notes: The resolutions were approved, with no amendments or qualifications, by all the Board Members.
There being no further matters to discuss, the meeting was concluded and these minutes were written, read, passed, and signed by all Directors present.
Pedro Wongtschowski – Chairman
Lucio de Castro Andrade Filho – Vice-Chairman
Alexandre Teixeira de Assumpção Saigh
Ana Paula Vitali Janes Vescovi
Flávia Buarque de Almeida
Jorge Marques de Toledo Camargo
José Galló
José Luiz Alquéres
José Mauricio Pereira Coelho
Marcos Marinho Lutz
Otávio Lopes Castello Branco Neto
André Brickmann Areno – Secretary
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
Date: May 19, 2021
|
ULTRAPAR HOLDINGS INC. |
|
|
By: /s/ Rodrigo de Almeida Pizzinatto |
|
|
Name: Rodrigo de Almeida Pizzinatto |
|
|
Title: Chief Financial and Investor Relations Officer |
(Minutes of the Meeting of the Board of Directors of Ultrapar Participações S.A., held on May 18, 2021)